Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo Philipp Treskes, PhD, Klaus.

Slides:

Advertisements

Similar presentations

Volume 15, Issue 3, Pages (March 2007)

Advertisements

In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography Osamu Ishii, MD, Michael Shin,

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery Shu-Hong.

Manuel J. Antunes, MD, PhD, DSc

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery Shu-Hong.

Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis

Epicardial infarct repair with basic fibroblast growth factor–enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling Holly E.M.

Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading Jeremias Wohlschlaeger,

Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac.

Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3–deficient mice Denis.

Global Gene Expression Analysis in PKCα−/− Mouse Skin Reveals Structural Changes in the Dermis and Defective Wound Granulation Tissue Nichola H. Cooper,

Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans Katharina Krenn, MD, Matthias Gmeiner, MD, PhD, Patrick Paulus, MD, Nezir.

Edaravone promotes activation of resident cardiac stem cells by transplanted mesenchymal stem cells in a rat myocardial infarction model Guang-Wei Zhang,

Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections Faustino A. Toba, PhD, Hirokazu.

Experimental generation of a tissue-engineered functional and vascularized trachea Thorsten Walles, MD, Bettina Giere, Michael Hofmann, PhD, Johanna Schanz,

Gorav Ailawadi, MD, Christopher W. Moehle, BS, Hong Pei, MD, Sandra P

Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium Klaus Neef, PhD, Yeong-Hoon Choi, MD, Sureshkumar.

Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction Tamotsu Yasuda, MD, PhD, Richard D. Weisel,

Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts Damiano Mugnai, MD, Jean-Christophe Tille, MD,

Diabetic hearts have lower basal urocortin levels that fail to increase after cardioplegic arrest: Association with increased apoptosis and postsurgical.

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold

Changfa Guo, MD, Husnain Kh. Haider, PhD, Winston S. N

Transplantation of autologous endothelial progenitor cells in porous PLGA scaffolds create a microenvironment for the regeneration of hyaline cartilage.

Transgenic model of cardiac rhabdomyosarcoma formation

Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic.

Afshin Ehsan, MD, Adam P. McGraw, PhD, Mark J

Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis Jiang-Yong Min, MD, Yu Chen, MD, Sohail.

Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model Derek J. MacDonald, MD, Jun Luo,

Electromechanical characterization of a tissue-engineered myocardial patch derived from extracellular matrix Takeyoshi Ota, MD, PhD, Thomas W. Gilbert,

Building a bioartificial heart: A 3-song saga

A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model Qi Zhou, MD, PhD, Jian-Ye.

Myocardial regeneration for chronic heart failure: Not as easy as it sounds Richard A. Hopkins, MD The Journal of Thoracic and Cardiovascular Surgery

Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction Jiang-Yong Min, MD, Xuling Huang, MD,

Preventing cardiac remodeling: The combination of cell-based therapy and cardiac support therapy preserves left ventricular function in rodent model of.

Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle Theo Kofidis, MD,

Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure Mark F. Berry, MD, Timothy.

Vascular endothelial growth factor transgene expression in cell-transplanted hearts Terrence M. Yau, MD, MSc, Guangming Li, MD, Richard D Weisel, MD,

Transplantation of alveolar type II cells stimulates lung regeneration during compensatory lung growth in adult rats Hironobu Wada, MD, PhD, Shigetoshi.

Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function

Vascular Endothelial Growth Factor Prevents Endothelial-to-Mesenchymal Transition in Hypertrophy Ben M.-W. Illigens, MD, Alejandra Casar Berazaluce,

Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model Kai Hong Wu, MD, PhD, Bin Zhou, PhD, Cun Tao Yu,

Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: Heart status and cell distribution Hao Zhang, MD, PhD,

Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor Matthias.

Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury Ingeborg Friehs, MD, Adrian M Moran, MD, Christof Stamm, MD, Yeong-Hoon.

Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors Mohammad H. Eslami, MD, Sidhu P. Gangadharan, MD,

Volume 19, Issue 11, Pages (November 2011)

Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model Yasuhiro.

Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium Yeong-Hoon Choi, MD, Douglas B. Cowan, PhD,

Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia/reperfusion Aditya K. Kaza, MD, Isaac Wamala, MD, Ingeborg.

In situ constructive myocardial remodeling of extracellular matrix patch enhanced with controlled growth factor release Akiko Tanaka, MD, PhD, Keigo.

Min Li, M. Sc. , Dong Liu, M. Sc. , Li Wang, Ph. D. , Weizhou Wang, B

Volume 56, Issue 4, Pages (October 1999)

Volume 12, Issue 6, Pages (December 2005)

Robotic minimally invasive cell transplantation for heart failure

Cellular therapy reverses myocardial dysfunction

A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladder matrix Takeyoshi.

Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart Naosumi Sekiya, MD, Goro Matsumiya, MD, PhD, Shigeru.

Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy Jiashing Yu,

Tetsuro Sakai, MD, Ren-Ke Li, MD, MSc, PhD, Richard D

Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model Hiroki Hata, MD, Goro Matsumiya, MD, PhD,

Volume 21, Issue 3, Pages (March 2013)

Zhi Cui, MSc, Ren-Ke Li, MD, PhD

Myoblast-seeded biodegradable scaffolds to prevent post–myocardial infarction evolution toward heart failure Matthias Siepe, MD, Marie-Noëlle Giraud,

Vascular Endothelial Growth Factor Receptor Upregulation in Response to Cell-Based Angiogenic Gene Therapy Terrence M. Yau, MD, MS, Guangming Li, MD,

Discussion The Journal of Thoracic and Cardiovascular Surgery

Volume 24, Issue 1, Pages (January 2016)

Implantation of fetal rat lung fragments into bleomycin-induced pulmonary fibrosis Hiroaki Toba, MD, Shoji Sakiyama, MD, PhD, Koichiro Kenzaki, MD, PhD,

Volume 20, Issue 1, Pages (January 2012)

Volume 15, Issue 9, Pages (September 2007)

Presentation transcript:

Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo Philipp Treskes, PhD, Klaus Neef, PhD, Sureshkumar Perumal Srinivasan, MSc, Marcel Halbach, MD, Christof Stamm, MD, Douglas Cowan, PhD, Maximilian Scherner, MD, Navid Madershahian, MD, Thorsten Wittwer, MD, Jürgen Hescheler, MD, Thorsten Wahlers, MD, Yeong-Hoon Choi, MD The Journal of Thoracic and Cardiovascular Surgery Volume 149, Issue 1, Pages 348-356 (January 2015) DOI: 10.1016/j.jtcvs.2014.09.034 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Experimental workflow from cell isolation and purification to tissue engineering and functional in vivo analysis of grafted tissue by sharp electrode measurement. Overview of the steps involved in primary cell isolation and processing. After isolation, cells were purified by preplating. The adherent cell population after preplating contained predominantly skeletal myoblasts. Scale represents 100 μm. These cells were expanded and seeded into a collagen-based matrix and either dropped into a dish as a control or cast into a mold (3 cm in length) for passive mechanical preconditioning during polymerization. These preconditioned (P) or nonpreconditioned (NP) engineered tissue constructs (ETCs) were fabricated and prelabeled with DiI, before they were transplanted epicardially to mouse hearts. Animals were then placed in animal holding for recovery. After 1 week, hearts were explanted for various analyses as detailed in the text. For sharp electrode measurements, whole hearts were embedded in a cylinder of agarose and sectioned using a microtome into 200-μm-thick viable heart slices. Slices were equilibrated in medium and transferred to a sharp electrode measurement setup. Responsive slices carrying parts of the grafted ETC (scale represents 100 μm) were measured and analyzed. PCR, Polymerase chain reaction. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 348-356DOI: (10.1016/j.jtcvs.2014.09.034) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Persistence and integrity of engineered tissue constructs (ETC) transplanted heart sections. A and B, Preconditioned (P) or nonpreconditioned (NP) ETCs, fabricated and prelabeled with DiI (inserts, red) before transplantation. C, Representative microphotograph of an explanted heart 1 week after transplantation of a P-ETC (arrow). D, Polymerase chain reaction detection of the mouse Y-chromosome–specific SRY gene performed on whole heart lysates of P-ETC transplanted mice 2, 3, 4, 6, and 10 weeks after transplantation versus a control without genetic material (handling control [HC]), male heart lysate as a positive control (+), and a female C57BL/6 heart lysate as a negative control (−). M is a molecular weight indicator allowing the detection of the 402-bp-long product (as indicated, the region of interest on the gel between 300 and 650 bp is shown here). E and F, Full section of a P-ETC (E) or NP-ETC (F) transplanted heart 1 week after transplantation, demonstrating the high content of extracellular matrix proteins (blue) of the graft by Masson's trichrome staining (scale represents 1 mm). G and H, Immunofluorescent staining of hearts sectioned 1 week after transplantation of P-ETC (G) and NP-ETC (H) showing DiI staining (red) of skeletal myoblasts and expression of desmin (green). Scale represents 100 μm. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 348-356DOI: (10.1016/j.jtcvs.2014.09.034) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Histologic analysis of engineered tissue construct (ETC) transplanted heart sections. Parallel sections from explanted hearts 1 week after construct transplantation stained against various structural and functional maturation markers (4′,6-diamidino-2-phenylindole in blue). Desmin (green) stainings of preconditioned (P)-ETC (A) and nonpreconditioned (NP)-ETC (B) grafted heart sections show pronounced desmin expression in the graft-to-host border zone, indicating the formation of young myoblasts (inserts display the same pictures with DiI fluorescence overlayed). Scale bars represent 500 μm. Dystrophin (green) stainings of P-ETC (C) and NP-ETC (D) grafted heart sections show strongest expression of dystrophin toward the core of the graft, indicating advancing functional maturation (inserts display the same pictures with DiI fluorescence overlayed). Scale bars represent 100 μm. Double staining of P-ETC (E) and NP-ETC (F) grafted heart sections against connexin 43 (green) and cardiac troponin I (red) shows ordered cardiac troponin I expression in the host tissue in both sections, which is absent in the ETC region. Furthermore, stronger connexin 43 expression organized in foci between the graft and host tissue was present in P-ETC grafted hearts compared with NP-ETC grafted hearts. Scale represents 100 μm. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 348-356DOI: (10.1016/j.jtcvs.2014.09.034) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Electrophysiologic examination of viable engineered tissue construct (ETC) transplanted heart slices. A and B, Microphotograph of a preconditioned (P)-ETC (A) or nonpreconditioned (NP)-ETC (B) transplanted viable heart slice 1 week after surgery as seen during measurement. Overlay of phase contract and fluorescent images displaying the electrode positions for ETC stimulation (S1) and host stimulation (S2) as well as the position of the recording electrode in the host myocardium (M). Scale bar represents 1 mm. C and D, Assessment of ETC to host coupling. In P-ETCs (C), myocardial action potentials are generated through ETC stimulation, whereas NP-ETC stimulation (D) is unsuccessful in entraining spontaneous host myocardial activity. E, Representative overlay of myocardial action potentials evoked by unipolar stimulation in P-ETC transplanted heart sections at (S1) and the host (S2) highlighting the difference in delay between stimulation and myocardial action potential generation at similar electrode distances. Scale represents 100 milliseconds (x-axis), 20 mV (y-axis). F, Graphical representation of calculated conduction velocity displaying significantly lower velocity of P-ETC to host conduction (P-ETC) than direct intramyocardial stimulation (Host). ***P < .001. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 348-356DOI: (10.1016/j.jtcvs.2014.09.034) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Assessment of coupling quality between grafted preconditioned (P) engineered tissue constructs and host myocardium. A-D, Assessment of the maximum frequency of 1:1 generation of action potentials. A, Induction of myocardial action potential generation followed stimulation in the P-engineered tissue construct (ETC) up to 8 Hz, but shows a 2:1 conduction block under stimulation at 10 Hz (B), whereas it follows 10 Hz stimulation of the host (C). D, Average maximum stimulation frequency from P-ETC or host for myocardial action potential generation without conduction blocks. E-H, Assessment of the robustness of electrophysiologic coupling by pharmacologic inactivation of gap junctions. Myocardial action potentials were generated through P-ETC stimulation at 4 Hz (E). Application of 1-heptanol led to a block of conduction between graft and host (F), which did not influence conduction in the host tissue, as shown by direct intramyocardial stimulation of the host (G). H, Average 1-heptanol concentrations for blocking myocardial action potential generation through P-ETC or host stimulation. Scales represent 100 milliseconds (x-axis) and 20 mV (y-axis); ***P < .001. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 348-356DOI: (10.1016/j.jtcvs.2014.09.034) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions